How to Buy a Home Health Agency in 2026

Home health is one of the most regulated and most misunderstood verticals in healthcare M&A. I've worked on home health transactions where the buyer thought they were acquiring a simple service business and discovered during diligence that they were actually navigating a maze of Medicare certification, state licensure, survey compliance, and reimbursement methodology that makes standard business acquisitions look trivial by comparison.

That complexity is also what makes home health agencies valuable — the regulatory barriers to entry create a defensible moat. A Medicare-certified home health agency with strong star ratings and clean survey history in a Certificate of Need state is an asset that cannot be replicated simply by spending money. Here's how to evaluate one.

Medicare Certification Transfer: The Foundation of the Deal

The Medicare certification (CMS Certification Number, or CCN) is the single most valuable asset in a home health acquisition. Without it, you cannot bill Medicare — and Medicare represents 60-80% of revenue for most home health agencies. The transfer process is governed by CMS regulations and involves your state's health department as the survey agency.

Change of ownership (CHOW) is the formal process for transferring a Medicare provider agreement. CMS requires the new owner to submit a CMS-855A enrollment application, undergo a state survey within 90 days of the ownership change, and demonstrate compliance with all Conditions of Participation. The critical detail: during the CHOW process, the agency can continue to operate and bill Medicare under the existing CCN. But if the new owner fails the survey, Medicare billing stops immediately.

Survey historyis therefore essential diligence. Request the agency's last three survey reports from the state health department. Condition-level deficiencies (as opposed to standard-level) are serious — they require a plan of correction and can trigger a follow-up survey. An agency with condition-level deficiencies on its most recent survey is a higher-risk acquisition because the incoming CHOW survey will scrutinize whether those issues have been resolved.

Timing:The CHOW process typically takes 60-120 days from application to survey completion. Plan your deal timeline accordingly. I've seen buyers structure deals with a signing-to-closing gap of 90-120 days specifically to accommodate the CHOW process, with the seller continuing to operate during the interim period under a management services agreement.

Star Rating Evaluation: What the Numbers Actually Mean

CMS publishes star ratings for every Medicare-certified home health agency on Home Health Compare. These ratings — quality of patient care and patient survey results — are increasingly important for both reimbursement and referral source relationships.

Quality of patient care stars (1-5) are calculated from OASIS assessment data and claims. They measure outcomes like improvement in ambulation, pain management, timely initiation of care, and hospitalization rates. A 4-star or above agency demonstrates clinical competence that translates to referral source confidence — hospitals and physicians send patients to agencies they trust to keep readmission rates low.

Patient survey stars come from HHCAHPS (Home Health Consumer Assessment of Healthcare Providers and Systems) surveys sent to discharged patients. These measure patient experience and are harder to manipulate than clinical metrics. Agencies with 4+ star patient surveys have genuine service quality that a new owner can maintain.

The valuation impact is direct: agencies with 4+ overall stars trade at a 15-25% premium to agencies with 3 stars or below. In competitive markets, a 4.5-star agency may receive multiple offers at 8-12x EBITDA, while a 2.5-star agency in the same market struggles to attract offers above 5-6x. Stars are earned over 12+ months of performance, so you can't buy a low-rated agency and flip the rating quickly.

PDGM Impact: Understanding the Reimbursement Engine

The Patient-Driven Groupings Model (PDGM) replaced the old PPS model in 2020 and fundamentally changed home health economics. If you're acquiring a home health agency, you need to understand PDGM at a granular level because it determines how the business generates cash.

Under PDGM, reimbursement is determined by clinical grouping, functional level, comorbidity adjustment, admission source (institutional vs. community), and timing (early vs. late 30-day period). The model eliminated therapy volume as a payment driver — which destroyed agencies that had been built around high-therapy-visit models.

What to analyze in diligence:Request a case mix analysis showing the distribution of PDGM payment groups for the last 12 months. You want to understand the agency's average reimbursement per 30-day period, LUPA (Low Utilization Payment Adjustment) rate, and the percentage of episodes that are institutional vs. community admissions. Institutional admissions reimburse higher, but they also require stronger hospital relationships to sustain.

LUPA rate deserves special attention. A LUPA occurs when the agency provides fewer visits than the threshold for full payment — meaning they get paid per visit instead of per episode. Industry-average LUPA rates are 8-10%. An agency running above 15% has an operational problem: either poor scheduling, staffing shortages, or patient non-compliance. Each LUPA episode can cost the agency $1,500-2,500 in lost reimbursement compared to full-episode payment.

Certificate of Need Requirements

As of 2026, approximately 18 states maintain Certificate of Need (CON) requirements for home health agencies. In these states, you cannot open a new Medicare-certified home health agency without state approval — which makes existing agencies in CON states inherently more valuable because the supply of competitors is artificially constrained.

CON states include Alabama, Arkansas, Georgia, Kentucky, Mississippi, Montana, New York, North Carolina, South Carolina, Tennessee, Virginia, Washington, and West Virginia, among others. The specifics change — states occasionally repeal or modify CON laws — so verify current status with the state health planning agency.

In CON states, the valuation multiple premium is measurable. An agency in a CON state with the same financial profile as one in a non-CON state will typically command 1.5-2.5x higher EBITDA multiples. The CON effectively functions as an intangible asset — a regulatory license to operate that competitors cannot obtain without going through a lengthy and uncertain state approval process.

Transfer mechanics:In most CON states, the CON transfers with the business as long as the new owner commits to maintaining the same scope of services in the same service area. Some states require prior approval of the transfer, adding 30-60 days to the timeline. Your healthcare M&A attorney needs to confirm the transfer requirements in your specific state before you sign an LOI.

Staffing Assessment: The Operational Reality

Home health is a labor-intensive business where clinicians — registered nurses, physical therapists, occupational therapists, speech therapists, home health aides — are the product. The staffing assessment in a home health acquisition isn't just an HR exercise; it's a capacity and revenue analysis.

Clinician-to-census ratiotells you whether the agency is adequately staffed for its current patient volume and whether it has capacity to grow. A full-time RN case manager should carry 25-30 active patients. A full-time PT should manage 6-8 visits per day. If the agency is running clinicians above these thresholds, it's likely experiencing burnout, overtime costs, and potential quality issues.

Contractor vs. employee mix directly impacts margins and risk. Agencies that rely heavily on per-visit contract clinicians (PRN staff) have lower fixed costs but higher per-visit expenses and less control over quality and scheduling. Agencies with a predominantly employed clinical staff have higher fixed costs but better margins at scale. Buyers generally prefer a 70%+ employed staff model for operational stability.

Turnover datais essential. Annual clinician turnover above 25% signals compensation, culture, or management issues that will persist post-acquisition. Request a roster of all clinical staff with hire dates, compensation, and FTE status. Calculate 12-month and 24-month retention rates. In the current labor market, agencies with turnover below 20% are managing something well — and that "something" is worth paying for.

Referral source relationshipsare people-dependent. If the agency's census is driven by one or two clinical liaisons who have relationships with local hospital discharge planners, understand what happens to those relationships if those individuals leave. The best agencies have relationships institutionalized across multiple staff members, not concentrated in a single person.

The Bottom Line

Buying a home health agency is not a business acquisition — it's a regulatory asset acquisition with a service business attached. The Medicare certification, star ratings, CON status, and survey history are what you're paying for. The clinical staff and referral relationships are what make it run. Get the regulatory diligence right, verify the reimbursement mechanics under PDGM, and confirm the clinical team will stay through the transition. If all three check out, home health agencies in good markets with strong ratings remain one of the best risk-adjusted investments in healthcare services.

The buyers who overpay are the ones who evaluate home health like a generic service business and discover the regulatory complexity after signing the LOI. The buyers who create value are the ones who understand that the regulatory barriers that make diligence difficult are the same barriers that protect their investment after close.